Reports of Radiotherapy and Oncology

Published by: Kowsar

A Review of Chemotherapy for Locally Advanced Head and Neck Cancers

Mohammad Shabani 1 and Mohammad Hassan Larizadeh 2 , *
Authors Information
1 Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, IR Iran
2 Research Center for Health Management Services, Kerman University of Medical Sciences, Kerman, IR Iran
Article information
  • Reports of Radiotherapy and Oncology: January 28, 2015, 2 (1); e2261
  • Published Online: January 24, 2015
  • Article Type: Review Article
  • Received: November 28, 2013
  • Revised: December 16, 2015
  • Accepted: December 28, 2015
  • DOI: 10.5812/rro.2(1)2015.2261

To Cite: Shabani M, Larizadeh M H. A Review of Chemotherapy for Locally Advanced Head and Neck Cancers, Rep Radiother Oncol. 2015 ; 2(1):e2261. doi: 10.5812/rro.2(1)2015.2261.

Abstract
Copyright © 2015, Iranian Society of Clinical Oncology.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnotes
References
  • 1. Posner M. Evolving strategies for combined-modality therapy for locally advanced head and neck cancer. Oncologist. 2007; 12(8): 967-74[DOI][PubMed]
  • 2. Posner MR. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy. Oncologist. 2005; 10 Suppl 3: 11-9[DOI][PubMed]
  • 3. Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, et al. Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach. Semin Oncol. 2004; 31(6): 778-85[PubMed]
  • 4. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991; 324(24): 1685-90[DOI][PubMed]
  • 5. Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004; 22(1): 69-76[DOI][PubMed]
  • 6. Domenge C, Hill C, Lefebvre JL, De Raucourt D, Rhein B, Wibault P, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J Cancer. 2000; 83(12): 1594-8[DOI][PubMed]
  • 7. Paccagnella A, Orlando A, Marchiori C, Zorat PL, Cavaniglia G, Sileni VC, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst. 1994; 86(4): 265-72[PubMed]
  • 8. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996; 88(13): 890-9[PubMed]
  • 9. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003; 349(22): 2091-8[DOI][PubMed]
  • 10. Semrau S, Waldfahrer F, Lell M, Linke R, Klautke G, Kuwert T, et al. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. Strahlenther Onkol. 2011; 187(1): 15-22[DOI][PubMed]
  • 11. Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 1998; 34(3): 224-8[PubMed]
  • 12. Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, et al. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol. 2007; 25(25): 3971-7[DOI][PubMed]
  • 13. Bourhis J, Guigay J, Temam S, Pignon JP. Chemo-radiotherapy in head and neck cancer. Ann Oncol. 2006; 17 Suppl 10-41[DOI][PubMed]
  • 14. Adelstein DJ. Induction chemotherapy in head and neck cancer. Hematol Oncol Clin North Am. 1999; 13(4): 689-98[PubMed]
  • 15. Cohen EE, Lingen MW, Vokes EE. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol. 2004; 22(9): 1743-52[DOI][PubMed]
  • 16. Kies MS. Induction chemotherapy for squamous cancer of the head and neck. Curr Oncol Rep. 2007; 9(2): 129-33[PubMed]
  • 17. Adelstein DJ. Redefining the role of induction chemotherapy in head and neck cancer. J Clin Oncol. 2008; 26(19): 3117-9[DOI][PubMed]
  • 18. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med. 2001; 345(26): 1890-900[DOI][PubMed]
  • 19. Majem M, Mesia R, Manos M, Gomez J, Galiana R, Cardenal F, et al. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Laryngoscope. 2006; 116(9): 1651-6[DOI][PubMed]
  • 20. Hitt R. Induction Chemotherapy in head and neck cancer. Annal Oncol. 2006; 17: 42-4
  • 21. Salvajoli JV, Morioka H, Trippe N, Kowalski LP. A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 1992; 249(4): 211-5[PubMed]
  • 22. Stell PM, Dalby JE, Strickland P, Fraser JG, Bradley PJ, Flood LM. Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol. 1983; 34(4): 463-7[PubMed]
  • 23. Toohill RJ, Anderson T, Byhardt RW, Cox JD, Duncavage JA, Grossman TW, et al. Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report. Arch Otolaryngol Head Neck Surg. 1987; 113(7): 758-61[PubMed]
  • 24. Martin M, Hazan A, Vergnes L, Peytral C, Mazeron JJ, Senechaut JP, et al. Randomized study of 5 fluorouracil and cis platin as neoadjuvant therapy in head and neck cancer: a preliminary report. Int J Radiat Oncol Biol Phys. 1990; 19(4): 973-5[PubMed]
  • 25. Richard JM, Kramar A, Molinari R, Lefebvre JL, Blanchet F, Jortay A, et al. Randomised EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer. 1991; 27(7): 821-7[PubMed]
  • 26. Jaulerry C, Rodriguez J, Brunin F, Jouve M, Mosseri V, Point D, et al. Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int J Radiat Oncol Biol Phys. 1992; 23(3): 483-9[PubMed]
  • 27. Athanasiadis I, Taylor S, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, et al. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Cancer. 1997; 79(3): 588-94[PubMed]
  • 28. Volling P, Schroder M, Eckel H, Ebeling O, Stennert E. [Results of a prospective randomized trial with induction chemotherapy for cancer of the oral cavity and tonsils]. HNO. 1999; 47(10): 899-906[PubMed]
  • 29. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998; 338(25): 1798-804[DOI][PubMed]
  • 30. Adelstein DJ, Li Y, Adams GL, Wagner HJ, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003; 21(1): 92-8[PubMed]
  • 31. Coughlin CT, Richmond RC. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol. 1989; 16(4 Suppl 6): 31-43[PubMed]
  • 32. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol. 1990; 8(5): 911-34[PubMed]
  • 33. Schnabel T, Zamboglou N, Kolotas C, Hartmann A, Schmitt G. Combined radiochemotherapy with carboplatin in the treatment of advanced head and neck carcinomas. Oncology. 1993; 50 Suppl 2: 16-22[PubMed]
  • 34. Argiris A, Haraf DJ, Kies MS, Vokes EE. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure. Oncologist. 2003; 8(4): 350-60[PubMed]
  • 35. Prades JM, Schmitt TM, Timoshenko AP, Simon PG, de Cornulier J, Durand M, et al. Concomitant chemoradiotherapy in pyriform sinus carcinoma. Arch Otolaryngol Head Neck Surg. 2002; 128(4): 384-8[PubMed]
  • 36. Vokes EE, Kies MS, Haraf DJ, Stenson K, List M, Humerickhouse R, et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol. 2000; 18(8): 1652-61[PubMed]
  • 37. Bernier J, Cooper JS. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? Oncologist. 2005; 10(3): 215-24[DOI][PubMed]
  • 38. Adelstein DJ, Saxton JP, Lavertu P, Rybicki LA, Esclamado RM, Wood BG, et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol. 2002; 20(5): 1405-10[PubMed]
  • 39. Cooper JS, Ang KK. Concomitant chemotherapy and radiation therapy certainly improves local control. Int J Radiat Oncol Biol Phys. 2005; 61(1): 7-9[DOI][PubMed]
  • 40. Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol. 1989; 16(2): 83-101[PubMed]
  • 41. Mosallaee A, Larizadeh MH, Saalabian MJ, Ahmady Kohanali J. Study of the role of combined radiotherapy & Chemotherapy in treatment of squamous cell tumors of head and neck. J Res Med Sci. 2003; 8(4): 88-5
  • 42. Merlano M, Vitale V, Rosso R, Benasso M, Corvo R, Cavallari M, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med. 1992; 327(16): 1115-21[DOI][PubMed]
  • 43. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998; 16(4): 1318-24[PubMed]
  • 44. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999; 91(24): 2081-6[PubMed]
  • 45. Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000; 88(4): 876-83[PubMed]
  • 46. Forastiere AA, Maor M, Weber RS, Pajak T, Glisson B, Trotti A, et al. Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx--Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. J Clin Oncol. 2006; 24(18_suppl): 284
  • 47. Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst. 1992; 84(11): 877-82[PubMed]
  • 48. Vokes EE, Kies M, Haraf DJ, Mick R, Moran WJ, Kozloff M, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol. 1995; 13(4): 876-83[PubMed]
  • 49. Urba S, Wolf G, Bradford C. Improved survival and decreased late salvage surgery using chemo-selection of patients for organ preservation in advanced laryngeal cancer. Proc Am Soc Clin Oncol. 2003; 22(1): 497
  • 50. Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA, et al. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol. 2001; 12(3): 343-7[PubMed]
  • 51. Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst. 2009; 101(3): 142-52[DOI][PubMed]
  • 52. Kies MS, Haraf DJ, Athanasiadis I, Kozloff M, Mittal B, Pelzer H, et al. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol. 1998; 16(8): 2715-21[PubMed]
  • 53. Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, et al. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol. 2004; 22(15): 3061-9[DOI][PubMed]
  • 54. Colevas AD, Norris CM, Tishler RB, Fried MP, Gomolin HI, Amrein P, et al. Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck. J Clin Oncol. 1999; 17(11): 3503-11[PubMed]
  • 55. Colevas AD, Norris CM, Tishler RB, Lamb CC, Fried MP, Goguen LA, et al. Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcADDIN EN.CITE.DATAinoma of the head and neck (SCCHN). Am J Clin Oncol. 2002; 25(2): 153-9[PubMed]
  • 56. Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, et al. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer. 2003; 97(2): 412-8[DOI][PubMed]
  • 57. Posner MR, Glisson B, Frenette G, Al-Sarraf M, Colevas AD, Norris CM, et al. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol. 2001; 19(4): 1096-104[PubMed]
  • 58. Colevas AD, Norris CM, Tishler RB, Lamb CC, Fried MP, Goguen LA, et al. Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN). Am J Clin Oncol. 2002; 25(2): 153-9[PubMed]
  • 59. Hitt R, Paz-Ares L, Brandariz A, Castellano D, Pena C, Millan JM, et al. Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial. Ann Oncol. 2002; 13(10): 1665-73[PubMed]
  • 60. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007; 357(17): 1695-704[DOI][PubMed]
  • 61. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007; 357(17): 1705-15[DOI][PubMed]
  • 62. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000; 355(9208): 949-55[PubMed]
  • 63. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol. 1996; 14(3): 838-47[PubMed]
  • 64. Su YX, Zheng JW, Zheng GS, Liao GQ, Zhang ZY. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis. Chin Med J (Engl). 2008; 121(19): 1939-44[PubMed]
  • 65. Watanabe A, Taniguchi M, Sasaki S. Induction chemotherapy with docetaxel, cisplatin, fluorouracil and l-leucovorin for locally advanced head and neck cancers: a modified regimen for Japanese patients. Anticancer Drugs. 2003; 14(10): 801-7[DOI][PubMed]
  • 66. Tsukuda M, Mikami Y, Tanigaki Y, Katori H, Horiuchi C, Ikeda Y, et al. Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck. Int J Clin Oncol. 2004; 9(3): 161-6[DOI][PubMed]
  • 67. Schrijvers D, Van Herpen C, Kerger J, Joosens E, Van Laer C, Awada A, et al. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study. Ann Oncol. 2004; 15(4): 638-45[PubMed]
  • 68. Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009; 101(7): 498-506[DOI][PubMed]
  • 69. Larizadeh MH, Damghani MA. Sequential chemoradiotherapy in advanced laryngeal cancer: an institutional experience. Asia Pac J Clin Oncol. 2010; 6(2): 106-10[DOI][PubMed]
  • 70. Larizadeh MH, Damghani MA. Expression of E-Cadherin in squamous cell carcinoma of the larynx and its correlation with clinicopathological features. J Med Sci. 2009; 9(1): 41-5
  • 71. Schrijvers D, Vermorken JB. Taxanes in the treatment of head and neck cancer. Curr Opin Oncol. 2005; 17(3): 218-24[PubMed]
  • 72. Gibson MK, Forastiere AA. Reassessment of the role of induction chemotherapy for head and neck cancer. Lancet Oncol. 2006; 7(7): 565-74[DOI][PubMed]
  • 73. Larizadeh MH, Nasirinejad Z. Radiotherapy for head and neck cancers: Indications and Techniques. 1388;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments